AI assistant
ArcticZymes Technologies — Share Issue/Capital Change 2014
Apr 9, 2014
3538_rns_2014-04-09_69fcddd9-8f1f-4110-b955-a7565050176e.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Biotec Pharmacon ASA - employee share issue registered in the Norwegian Register of Business Enterprises
Biotec Pharmacon ASA - employee share issue registered in the Norwegian Register of Business Enterprises
Reference is made to the stock exchange notice dated 8 April 2014
regarding the private placement directed at certain employees of Biotec
Pharmacon ASA completed on 7 April 2014.
The share capital increase approved by the Board in accordance with the
authorization granted by the General Meeting has been registered in the
Norwegian Register of Business Enterprises and the new shares have been
issued in VPS. The new registered share capital of Biotec Pharmacon ASA
is NOK 43 336 173 divided into 43 336 173 shares each with a par value
of NOK 1.